Different expression of p16INK4aand p14ARFin cervical and lung cancers

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 22, 2013, Pages 3007-3011

  Li, J G ^a   Li, Li ^b   Zhang, S W ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; Immunohistochemistry; Lung cancer; p14ARF; p16INK4a

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; P16 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER GROWTH; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MIDDLE AGED; NONHUMAN; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; WART VIRUS; YOUNG ADULT; AGED; CHEMISTRY; ISOLATION AND PURIFICATION; LUNG TUMOR; MALE; PAPILLOMA VIRUS; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P14ARF; UTERINE CERVICAL NEOPLASMS;

EID: 84891787182     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. NAM EJ, KIM JW, KIM SW, KIM YT, KIM JH, YOON BS, CHO NH, KIM S. The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance. Gynecol Oncol 2007; 104: 207-211.
2. KHOO CM, CARRASCO DR, BOSENBERG MW, PAIK JH, DEPINHO RA. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse. Proc Natl Acad Sci U S A 2007; 104: 3931-3936.
3. LI Y, YU Y, ZHANG Y, ZHOU Y, LI C, ZHU J, YUAN H, LU H. MAFIP is a tumor suppressor in cervical cancer that inhibits activation of the nuclear factor-kappa B pathway. Cancer Sci 2011; 102: 2043-2050.
4. DENNY L. The prevention of cervical cancer in developing countries. Br J Obstet Gynaecol 2005; 112: 1204-1212.
5. BLOKX WA, LESTERHUIS WJ, ANDRIESSEN MP, VERDIJK MA, PUNT CJ, LIGTENBERG MJ. CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma. Am J Surg Pathol 2007; 31: 637-641.
6. ISHIKAWA M, FUJII T, SAITO M, NINDL I, ONO A, KUBUSHIRO K, TSUKAZAKI K, MUKAI M, NOZAWA S. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int J Gynecol Cancer 2006; 16: 347-353.
7. MURPHY N, RING M, KILLALEA AG, UHLMANN V, O'DONOVAN M, MULCAHY F, TURNER M, MCGUINNESS E, GRIFFIN M, MARTIN C, SHEILS O, O'LEARY JJ. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003; 56: 56-63.
8. KANAO H, ENOMOTO T, UEDA Y, FUJITA M, NAKASHIMA R, UENO Y, MIYATAKE T, YOSHIZAKI T, BUZARD GS, KIMURA T, YOSHINO K, MURATA Y. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer. Cancer Lett 2004; 213: 31-37.
9. INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia. Int J Gynecol Pathol 2006; 25: 187-194.
10. GALMICHE L, COSTE-BUREL M, LOPES P, PHILLIPPE HJ, LABOISSE C. The expression of p16 is not correlated with HPV status in CINI. Histopathology 2006; 48: 767-769.